Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

Study of ARC-520 in Patient With Chronic Hepatitis B Virus

Overview Structured Data Issues Contributors Activity

clinicaltrials.gov/study/NCT02349126

Is a

‌

Clinical study

Clinical Study attributes

NCT Number

NCT023491260

Trial Recruitment Size

Trial Sponsor

Arrowhead Pharmaceuticals

Clinical Trial Start Date

2015

Primary Completion Date

2015

Study Completion Date

2016

Clinical Trial Study Type

Interventional0

Interventional Trial Purpose

Treatment0

Intervention Type

Drug0

Intervention Name

ARC-520 Injection0

Interventional Trial Phase

Phase 20

Last Updated

August 14, 2015

Allocation Type

NA0

Intervention Model

Single Group Assignment0

Masking Type

None (Open Label)0

Study summary

Patients with chronic HBV infection will receive ARC-520 in combination with entecavir or tenofovir and be evaluated for safety and efficacy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like Study of ARC-520 in Patient With Chronic Hepatitis B Virus

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API